Finoriq research workspace
Edwards Lifesciences Corp (EW) SEC Filings & Filing Highlights
Edwards Lifesciences Corporation provides products and technologies to treat advanced. Review EW SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
- Company
- Edwards Lifesciences Corp (EW)
- Ticker
- EW
- Market Cap
- $49B
- Latest Price
- $85.14
- Industry
- Industrial Specialties
Edwards Lifesciences Corp (EW) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Edwards Lifesciences Corp (EW).
| Event | Form | Date |
|---|---|---|
| The final results of voting for each matter submitted to a vote of stockholders at the Annual M...The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2026, are a... | 8-K5.07 | 2026-05-08 |
| Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program At the 2026...Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program At the 2026 Annual Meeting of Stockholders (the “Annual... | 8-K5.02 | 2026-05-08 |
| On May 4, 2026 the Company issued a press release announcing the appointment of Ms. Mistras as...On May 4, 2026 the Company issued a press release announcing the appointment of Ms. Mistras as the Corporate Vice President, Chief Financia... | 8-K7.01 | 2026-05-04 |
| On May 4, 2026, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), annou...On May 4, 2026, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), announced that Theodora Mistras has been appointe... | 8-K5.02 | 2026-05-04 |
| Edwards Lifesciences CorporationOne Edwards Way · Irvine, CA USA · 92614 | 8-K2.02 | 2026-04-23 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.